The CD22 gene gives B cells, a type of white blood cell, a surface protein that helps fine tune immune activity. In medicine, this gene is important because it helps regulate how strongly these cells respond. If the gene does not work properly, immune signals may become harder to control, which can play a role in some immune conditions and certain B cell leukemias or lymphomas. CD22 is best known in cancer care as a treatment target rather than as a widely recognized public gene.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the working parts of cells. Others mainly help determine when certain processes happen, where they take place, and how strongly they operate. Taken together, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. To look into this topic in greater depth, you can find more in the LearnHub.
Overview
CD22Gene function
What if the gene works
The CD22 gene helps control how B cells, a type of immune cell, respond to germs. Its protein acts like a brake, keeping immune signals balanced and helping the body avoid overreacting.
Risk
What if the gene does not work
Milder to more severe variants in the CD22 gene can reduce how well B cells receive braking signals, lowering surface levels of the CD22 protein or its sugar binding. This may weaken control of B cell activation.
Treatment
What does that mean for your treatment
No CD22-specific treatment or management approach is currently established for people with a pathogenic variant in the CD22 gene. Separately, CD22 on B cells is a well-established drug target in some leukemias and lymphomas, where anti-CD22 therapies may be used based on the cancer’s features rather than an inherited CD22 variant.
Gene function
What if the gene works
CD22 helps fine tune how B cells, a type of white blood cell, handle immune signals. When this gene works normally, these cells respond in a measured way and stay connected to cues from nearby cells. This supports steady day to day immune function and helps explain how the CD22 gene controls B cell signaling.
The CD22 gene helps put a brake on signals that start when a B cell's surface sensor is triggered. This keeps activation more measured during normal immune responses.
Its protein recognizes sialic acids (common sugar marks on cell surfaces). This helps B cells read nearby cells and fine tune how strongly they react.
CD22 also helps B cells make brief contacts with other cells through those surface sugars. These contacts support normal immune communication and help organize signaling at the cell surface.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including variations in appearance, metabolism, and the way the body responds to environmental influences. Many do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CD22 gene can change how much CD22 reaches the B cell surface, how well it recognizes sugar tags, and how strongly it signals inside the cell. How variants in the CD22 gene affect B cell signaling often depends on whether the change mildly lowers protein stability or causes a severe loss of surface expression or signaling. Some variants also change how the gene's message is assembled, which can produce a shortened or less effective protein.
How variants are linked to conditions
The CD22 gene does not yet have a broadly confirmed link to a specific health condition, and research on how variants of the CD22 gene are linked to conditions is still developing. Anyone with a confirmed CD22-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant tied to a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CD22 gene itself. If CD22 comes up in your test results, the overall picture usually depends more on the exact genetic change, your personal health history, and family history.
Inheritance of CD22 variants
There is not yet a broadly confirmed single-gene inheritance pattern for CD22-related health conditions, so how CD22 gene variants are inherited is still being clarified as research develops. The CD22 gene is located on chromosome 19, which is an autosome. That means you inherit one copy of the CD22 gene from your mother and one copy from your father.
What does my CD22 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific, well-established inherited condition for CD22. If you have a CD22 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your exact finding and family history.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry changes in the CD22 gene, doctors use genetic testing for CD22 variants on a blood or saliva sample. A lab reads the gene’s DNA code and looks for variants, then compares any findings with well established medical databases to show whether a variant is known, likely harmless, or needs more interpretation.
When should I consider getting a genetic test?
There is not yet a broadly established reason to have genetic testing just for the CD22 gene. Decisions about testing are usually based on your personal health, family history, and whether a doctor or genetics specialist thinks a broader test could be helpful.
A genetic result is only one part of your health story
A genetic finding can provide useful information, though how much it explains depends on the condition and the kind of variant involved. Factors like lifestyle, environment, age, and medical history also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medications, genes influence how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. To explore this subject in more detail, you can learn more in the LearnHub.
Drugs influenced by the CD22 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines or side effects are best discussed with your doctor. CD22 is being studied in some blood cancers because certain treatments are designed to attach to the CD22 protein on B cells, but this has not become standard gene-based prescribing guidance.
History
The CD22 gene entered medical research through studies of B cells in the late 1980s, when scientists were mapping the surface markers that help distinguish one immune cell type from another. Initially understood only through visible traits, later recognized as tied to a specific gene, CD22 became an important reference point in blood cancer research. From these first observations, research expanded steadily as laboratories linked CD22 to certain leukemias and lymphomas. This made the CD22 gene useful not only for diagnosis but also for developing targeted treatments, including antibody based drugs and newer cell therapies. Over time, scientists’ understanding of the gene’s role has changed as immune biology became clearer. Today, CD22 remains best known in medicine for its place in the history of B cell markers and targeted cancer therapy.